“ When Antonio Avila came to Chile in 2011, one of his main goals was to adapt the business model to the current needs of the market.… ”
In Conversation
“ Chile witnessed increasing demand for vitamin and dietary supplements as a result of improvement of disposable incomes and living standards. Gerardo Sanchez saw an opportunity in… ”
“ Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a… ”
“ "In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes… ”
“ The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a… ”
“ Medtronic, world’s largest medical technology company ”
“ Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In… ”
“ “We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says… ”
“ Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. ”
“ Raúl Sánchez, general manager of Peri Logistics speaks about ”
“ of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its revenues in Latin America. ”
“ “70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, ”
